January 2022

Civica by the Numbers

Delivering vital medications

72M
vials or syringes
of essential
generic medications
to treat over
28M
patients

Solving critical drug shortages

60
Generic medications
available from Civica
11
Medications used to treat Covid-19

Building innovative partnerships

55
Health System Members
15
Manufacturing Partners

March 2022

Civica to Manufacture and Distribute Affordable Insulin

Through a transformative collaboration between Civica and dedicated partners representing nearly every corner of the diabetes ecosystem, Americans with diabetes will have access to more affordable insulins. This transparent, cost-plus model will drastically reduce out-of-pocket costs for insulin.

“Diabetes is arguably America’s most expensive chronic condition, and it is heartbreaking that millions of people are rationing their care and putting their lives at risk because they can no longer afford insulin. Through mission-driven partnerships, we are choosing to create a new market reality where no one is forced to ration essential diabetes medications.”

Dan Liljenquist
Board Chair of Civica
Chief Strategy Officer, Intermountain Healthcare

Media Coverage

Civica to Manufacture and Distribute Affordable Insulin
A Group of Hospitals Has a Plan to Get Around Congress’s Refusal to Lower the Cost of Insulin

Mayo-backed Nonprofit Civica Rx Plans to Make Low-cost Insulin Starting in 2024

Civica Rx Aims to Disrupt Generic Insulin Market Pricing by 2024
Civica Rx Thinks It Has a Cure for High Insulin Prices
Civica is Rallying Leaders to Make Insulin Affordable by 2024

March 24, 2022

Civica Hill Briefing: Civica to Manufacture and Distribute Affordable Insulin

April 1, 2022

Insulin Has Been Around for 100 Years, So Why Is It Still So Expensive?

“Our objective is to generate a societal return, improving affordability and alleviating human suffering while demonstrating that market solutions exist that can help moderate the effects of capitalism unrestrained by notions of right and wrong—models that put the needs of the patient first and always.”

Dan Liljenquist,
Board Chair of Civica
Chief Strategy Officer, Intermountain Healthcare
Martin VanTrieste
Civica President and CEO

Media Coverage

Insulin Has Been Around for 100 Years, So Why Is It Still So Expensive?

April 1, 2022

Civica Leads Biggest Economic Development in Petersburg, Virginia, in 40 Years

United States Senator Tim Kaine (D-Va.) and Petersburg Mayor Sam Parham join Civica leaders on-site at Civica’s manufacturing plant under construction in Petersburg, Virginia to tour and learn more about the project’s impact not only on the local economy but also ultimately on lowering the cost of pharmaceuticals around the world.
On left, Civica CEO Martin VanTrieste and Sen. Kaine tour the new facility. On right, Civica team members include (from left) Engineering Lead Jason Winfield, Petersburg Site Head Stan Benson, CEO Martin VanTrieste, and Chief Quality and Regulatory Affairs Officer Donna Gulbinski.
On left and right, views from the construction of Civica’s manufacturing plant in Petersburg, Virginia.

April 6, 2022

A Radical Treatment for Insulin Pricing

“If Civica does deliver on its plan, it will disrupt the status quo for an important set of drugs and establish a path for reducing prices for other biologic medications whose market exclusivity periods have passed.”

NEJM OpEd

Media Coverage

A Radical Treatment for Insulin Pricing

April 26, 2022

Diabetes Connections: We Can Do It – Civica Rx and Non-Profit Insulin

Hear from Civica Chief Operating Officer Ned McCoy on Civica’s plans to manufacture and sell three types of insulin for one low-cost to patients who require it – regardless of insurance coverage.

May 24, 2022

Civica Announces Leadership Transition

Effective June 1, Ned McCoy, formerly Civica’s Chief Operating Officer, succeeds Martin VanTrieste as Civica’s President and Chief Executive Officer. Martin remains an advisor to the Company and continues serving on Civica’s Board of Directors. As part of this transition, Ned also joins the Civica Board of Directors.

“I look forward to continuing to work with our talented team and furthering our culture of innovation, excellence and dedication to improving patient lives with a new model for generic hospital and prescription medicines.”

Ned McCoy
Civica President and Chief Executive Officer

Media Coverage

Civica Announces Leadership Transition
Civica Taps Current COO to Succeed VanTrieste as Chief Executive
Civica Taps Ned McCoy as New CEO
Civica Rx COO McCoy to Step into CEO Role from 1 June
Civica Names Ned McCoy as its CEO
Civica Selects Next CEO

June 1, 2022

A Conversation with Civica’s Affordable Insulin Initiative Leader

“Civica’s insulin project will ensure that patients have the capability to manage their insulin by making it available and affordable to all who need it.”

Tom Damratoski
Senior Vice President, Biopharmaceutical Products

June 2, 2022

Profil Selected as Clinical Trial Partner for Affordable Insulin Initiative

Civica chose Profil as clinical trial partner to support the development of its affordable insulin biosimilars. Profil is the leading clinical research organization for studies related to diabetes and obesity.

Media Coverage

Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative
Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative
Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative
Civica Signs Up Profil to Run Trials for Affordable Insulin Biosimilars
Civica Nabs Trial Partner as It Forges Ahead to Create More Affordable Insulins

June 14, 2022

Civica’s Sister Organization CivicaScript™ Welcomes New Members

CivicaScript™, Civica’s sister organization focused on lower prices at the pharmacy counter, welcomes new members EmsanaRx and Health Care Service Corporation.

Media Coverage

EmsanaRx Joins CivicaScript™ to Make Lower-Cost Generic Medicines Available to its Pharmacy Benefit Members
Health Care Service Corporation Joins CivicaScript™ to Make Lower-Cost Generic Medicines Available to its Members

June 15, 2022

A Dose of Prescription Drug Disruption

Gina Guinasso, President at CivicaScript, talks about the exorbitant costs in today’s prescription drugs and how her organization – together with the industry – is leveling the playing field by distributing generic drugs directly to pharmacies.